<DOC>
	<DOC>NCT02312479</DOC>
	<brief_summary>A prospective open-label, single treatment study to assess the safety and the performance of the Nyxoah SAT system for the treatment of Obstructive Sleep Apnea</brief_summary>
	<brief_title>Safety and Performance Study of the Nyxoah SAT System for Treating OSA</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Diagnosed with moderate to severe Obstructive Sleep Apnea Have failed or have not tolerated CPAP treatment Willing and capable of providing informed consent Willing and capable of returning to all followup visits and sleep studies, including evaluation procedures and filling out questionnaires BMI limits Subjects with complete concentric collapse at the soft palate level per endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>